Quanli Gao

2.7k citations
67 papers · 1.5k indexed · 1 hit paper · h-index 18
Topics
Cancer Immunotherapy and Biomarkers (31 papers)Immune Cell Function and Interaction (24 papers)CAR-T cell therapy research (17 papers)
Partner nations
ChinaUnited StatesNorway

In The Last Decade

Quanli Gao

63 papers receiving 1.4k citations

Hit Papers

Gasdermin E–mediated target cell pyroptosis by CAR T cell...20202026202220242020100200300400

Peers

Quanli Gao
Comparison fields: 5 of 89
  • Oncology 834
  • Molecular Biology 652
  • Immunology 582
  • Pulmonary and Respiratory Medicine 209
  • Cancer Research 159
Replace Marshall D. Behrens with:
Marshall D. Behrens United States
Beatrice Belmonte Italy
Xiaoyan Qiu China
Yu Xia China
Juan J. Roman United States
Mathieu Derouet Canada
Chunwan Lu United States
Jens Schreiner Germany
Satyaki Sengupta United States
Quanli Gao relative to Marshall D. Behrens United States Marshall D. Behrens's profile →
Citations per field
00.5×
Marshall D. Behrens · 1×
Citations per year

Countries citing papers authored by Quanli Gao

Since Specialization
Citations

This map shows the geographic impact of Quanli Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quanli Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quanli Gao more than expected).

Fields of papers citing papers by Quanli Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quanli Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quanli Gao. The network helps show where Quanli Gao may publish in the future.

Co-authorship network of co-authors of Quanli Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Quanli Gao. A scholar is included among the top collaborators of Quanli Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quanli Gao. Quanli Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 0
5 9
6 15
7 4
8 4
9 21
10 20
11 13
12 9
13 0
14 11
15 3
16 9
17 10
18 40
19 72
20 121

About Quanli Gao

Quanli Gao is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine, having authored 67 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (31 papers), Immune Cell Function and Interaction (24 papers) and CAR-T cell therapy research (17 papers). The work is most often cited by research in Oncology (834 citations), Immunology (582 citations) and Cancer Research (159 citations). Quanli Gao has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Zibing Wang, Brian G. Till, Liping Guo, Hongxia Li, Shih Hsin Lu, Lingdi Zhao, Ke Tang, Yuying Liu, Yiliang Fang and Tiepeng Li. Their work appears in journals such as Journal of Clinical Oncology, Blood and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026